Predict your next investment

HEALTHCARE
biosensetech.com

See what CB Insights has to offer

Stage

Dead | Dead

Total Raised

$530K

About Biosense Technologies

BioSense Technologies proposes the development of a new phenotypic assay for determining antibiotic minimum inhibitory concentrations (MIC) in 60 minutes. The technology monitors the development of antibiotic-induced cellular stress as an early response for determining the effect of therapeutic agents on cellular suspensions. The immediacy and ubiquity of the response enables near real-time assessment of all bacterial species treated with drugs having different mechanisms of action.

Biosense Technologies Headquarter Location

4 Arrow Drive

Woburn, Massachusetts, 01801,

United States

781-933-3635

Latest Biosense Technologies News

IIM-A incubator CIIE.co scores first health-tech exit with Biosense

Dec 6, 2019

VCCircle Indian Institute of Management, Ahmedabad’s startup incubator CIIE.Co has profitably exited its first health-tech investment. Mumbai-based Biosense Technologies, a diagnostics device maker has been acquired by Bengaluru-based in-vitro, kits and instruments provider Tulip Diagnostics. The terms of the deal were not disclosed. Tulip has a footprint in 70 countries across the world. Biosense was founded by Abhishek Sen, Yogesh Patil, Myshkin Ingawale, and Aman Midha and incubated by CIIE.Co a decade ago. Its devices are focussed on the detection and screening of conditions such as diabetes, anaemia and malnutrition. “The returns that we receive through this exit will be ploughed back to support more med-tech startups and entrepreneurs in the coming years. This exit also is an indicator that early-stage investments can be profitable and India has the potential to build medical device companies for global acquisitions,” Vipul Patel, partner, seed investing, at CIIE.Co, said. After being incubated at CIIE.Co, Insitor Fund, Menterra Social Impact Fund, The Lemelson Foundation and The Netri Foundation supported Biosense in various capacities, as per the statement. Prior to the acquisition, Biosense had raised at least $3.34 million in disclosed investment rounds according to data compiled by VCCEdge. CIIE.CO helps startups not only with incubation but also in terms of investments and acceleration programmes. It  provides infrastructure, training, and access to a network of collaborators. Other startups in the med-tech space in CIIE.Co’s portfolio include Crimson Health, Rcupe Life Sciences, OnwardAI, and iNICU, and Green Ocean Research Labs. Tags

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Biosense Technologies Patents

Biosense Technologies has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/11/2007

1/29/2013

Small nuclear RNA, Transcription factors, Cell biology, Molecular biology, Biotechnology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/11/2007

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

1/29/2013

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Small nuclear RNA, Transcription factors, Cell biology, Molecular biology, Biotechnology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.